Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Jul;10(1):25–27. doi: 10.1128/aac.10.1.25

Pharmacokinetic Parameters of Sisomicin

Burt R Meyers 1, Shalom Z Hirschman 1, Stanley Yancovitz 1, Bruce Ribner 1
PMCID: PMC429683  PMID: 984754

Abstract

Sisomicin in doses of 1 mg/kg was administered intramuscularly to 10 healthy volunteers, and 1 week later the same volunteers received sisomicin at the same dose intravenously. A peak serum concentration of sisomicin of 3.08 μg/ml was obtained 1 h after intramuscular injection, and a peak serum concentration of 7.12 μg/ml was achieved 30 min after a 30-min intravenous infusion. The sisomicin elimination data were analyzed according to a two-compartment model. Pharmacokinetic parameters derived from the intramuscular and intravenous studies were quite similar.

Full text

PDF
26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Greenblatt D. J., Kock-Weser J. Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med. 1975 Oct 2;293(14):702–705. doi: 10.1056/NEJM197510022931406. [DOI] [PubMed] [Google Scholar]
  2. Lode H., Kemmerich B., Koeppe P. [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin]. Antimicrob Agents Chemother. 1975 Oct;8(4):396–401. doi: 10.1128/aac.8.4.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Loo J. C., Riegelman S. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. J Pharm Sci. 1970 Jan;59(1):53–55. doi: 10.1002/jps.2600590107. [DOI] [PubMed] [Google Scholar]
  4. Martin C. M., Cuomo A. J., Geraghty M. J., Zager J. R., Mandes T. C. Gram-negative rod bacteremia. J Infect Dis. 1969 Apr-May;119(4):506–517. doi: 10.1093/infdis/119.4-5.506. [DOI] [PubMed] [Google Scholar]
  5. Meyers B. R., Hirschman S. Z. Pharmacologic studies on tobramycin and comparison with gentamicin. J Clin Pharmacol New Drugs. 1972 Aug-Sep;12(8):321–324. doi: 10.1002/j.1552-4604.1972.tb00174.x. [DOI] [PubMed] [Google Scholar]
  6. Meyers B. R., Leng B., Hirschman S. Z. Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother. 1975 Dec;8(6):757–758. doi: 10.1128/aac.8.6.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Regamey C., Gordon R. C., Kirby W. M. Comparative pharmacokinetics of tobramycin and gentamicin. Clin Pharmacol Ther. 1973 May-Jun;14(3):396–403. doi: 10.1002/cpt1973143396. [DOI] [PubMed] [Google Scholar]
  8. Rodriguez V., Bodey G. P., Valdivieso M., Feld R. Clinical pharmacology of sisomicin. Antimicrob Agents Chemother. 1975 Jan;7(1):38–41. doi: 10.1128/aac.7.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Siber G. R., Echeverria P., Smith A. L., Paisley J. W., Smith D. H. Pharmacokinetics of gentamicin in children and adults. J Infect Dis. 1975 Dec;132(6):637–651. doi: 10.1093/infdis/132.6.637. [DOI] [PubMed] [Google Scholar]
  10. Weinstein M. J., Marquez J. A., Testa R. T., Wagman G. H., Oden E. M., Waitz J. A. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic. J Antibiot (Tokyo) 1970 Nov;23(11):551–554. doi: 10.7164/antibiotics.23.551. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES